Michael Hund

Michael Hund, MBA, is an award winning CEO with more than 20 years of experience in the innovative business models of venture philanthropy, impact investing, medtech entrepreneurship, and driving results for rare disease patients. His leadership has been highlighted by MIT, Yale, Harvard, Stanford, Cambridge, Forbes, and the Milken Institute. He is the CEO of EB Research Partnership, a game changing medical research organization dedicated to curing EB and scaling their model to rare disease. Under his leadership EBRP has raised more than $80 million to transform the landscape from 2 to over 50 clinical trials and accelerated 3 FDA approved treatments. He is Executive Producer of the award-winning Netflix documentary Matter of Time, and Executive Producer of Venture into Cures, combining stories of the patient and medical communities with musicians, celebrities, and actors.

Previously he served as the Director for the Multiple Myeloma Research Foundation and Paul Newman’s Hole in the Wall Gang, working on behalf of children battling life threatening illnesses. Michael received his MBA from Yale University, CORe credential from Harvard Business School, and a degree in Philosophy from the University of Kansas. He is the recipient of the MIT Solve Innovation Award, iHeart Media’s CEOs You Should Know, the Milken Institute’s Changemaker and LeadersLink, Social Innovations Journal Leadership Award, Top 100 Magazine Innovators, and IAOTP’s Top CEO of the Year in Medical Research.